Deborah J. Andrews - Jul 1, 2025 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Alexandra Hernandez, as Attorney-in-Fact
Stock symbol
LCTX
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/2/2025, 09:00 PM
Previous filing
Jun 26, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ANDREWS DEBORAH J Director C/O LINEAGE CELL THERAPEUTICS, 2173 SALK AVENUE, SUITE 200, CARLSBAD /s/ Alexandra Hernandez, as Attorney-in-Fact 2025-07-03 0001325697

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Stock Option (Right to Buy) Award $0 +75K $0.00 75K Jul 1, 2025 Common Shares 75K $0.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Will vest and become exercisable on the earlier of July 1, 2026 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer.